Alimera Sciences Inc - Company Profile

All the sales intelligence you need on Alimera Sciences Inc in one solution.

Save hours of research time with a comprehensive
Sales Intelligence Solution.
Understand how Alimera Sciences Inc fits into your total
addressable market and Ideal Customer Profile.
Gain competitive edge with triggers that tell you
when and how to engage with Alimera Sciences Inc.

Alimera Sciences Inc: Premium Databases

Contact the team or request a demo to find out how our data can drive your business forward

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

Headline	Published	Journalists
Showing 3 of 4 results.
Deserunt mollit sunt Lorem laborum do id aliqua dolore	12 Feb 2015	Lorem
pSivida to approach FDA with plans for retinal vein occlusion Phase III; seeks CROs – CEO	11 Feb 2015	Alissa Fleck
Alimera may have deal for Iluvien approval in chronic DME subpopulation - experts	04 Feb 2014	Casey McDonald
Alimera contemplating Southern EU partnership for DME drug Iluvien, looking for Asia partner – CEO	03 Aug 2012	Casey McDonald

Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.

Drug Insights:

Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
Material intelligence on competitors, including breaking news
Insight on companies’ business development needs and strategies

Outsourcing Insights:

Insight on companies’ CRO and business development needs, strategies and relationships

Remove risk and uncertainty

Gain a competitive edge

Secure actionable leads

Gain a 360-degree view of Alimera Sciences Inc and make more informed decisions for your business

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer